Iterum Therapeutics Plc (ITRM)
0.488
+0.02
(+3.96%)
USD |
NASDAQ |
Dec 12, 10:48
Iterum Therapeutics Profit Margin (Quarterly): -2.30K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amarin Corp. Plc | -15.58% |
| Jazz Pharmaceuticals Plc | 22.33% |
| Prothena Corp. Plc | -1.51K% |
| GH Research Plc | -- |
| Mural Oncology Plc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -84.25% |
| Return on Invested Capital | -98.23% |
| Gross Profit Margin (Quarterly) | 3.85% |
| Operating Margin (Quarterly) | -1.98K% |
| Return on Net Operating Assets | -161.3% |